‘Gold Standard’ Clinical Trial Finds Hydroxychloroquine Won’t Prevent COVID-19
WEDNESDAY, June 3, 2020 — Hydroxychloroquine, the malaria drug touted and reportedly used by President Donald Trump as a preventative for COVID-19, appears not to have lived up to its hype, a new study shows. Unlike some prior studies, this new trial was a “gold standard” prospective, randomized clinical trial. It found that hydroxychloroquine could… Read More »